🔥🔥 Don’t Miss Out on Our End of Autumn Sale. If you have any questions, feel free to click the bottom right corner to contact our customer service..

Concat us[email protected]
Shopping Cart

No products in the cart.

🔍
BS EN ISO 27269:2022

BS EN ISO 27269:2022

$215.11

Health informatics. International patient summary

Published By Publication Date Number of Pages
BSI 2022 92
PDF Format Searchable Printable Preview Now
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This document defines the core data set for a patient summary document that supports continuity of care for a person and coordination of their healthcare. It is specifically aimed at supporting the use case’ scenario for ‘unplanned, cross border care’ and is intended to be an international patient summary (IPS). Whilst the data set is minimal and non-exhaustive, it provides a robust, well-defined core set of data items. The tight focus on this use case also enables the IPS to be used in planned care. This means that both unplanned and planned care can be supported by this data set within local and national contexts, thereby increasing its utility and value. It uses the European Guideline from the eHN as the initial source for the patient summary requirements, then takes into consideration other international patient summary projects to provide an interoperable data set specification that has global application. This document provides an abstract definition of a Patient Summary from which derived models are implementable. Due to its nature therefore, readers should be aware that the compliance with this document does not imply automatic technical interoperability; this result, enabled by this document, can be reached with the conformity to standards indicated in the associated technical specification and implementation guides. This document does not cover the workflow processes of data entry, data collection, data summarization, subsequent data presentation, assimilation, or aggregation. Furthermore, this document does not cover the summarization act itself, i.e. the intelligence/skill/competence that results in the data summarization workflow. It is not an implementation guide that is concerned with the various technical layers beneath the application layer. Implementation guidance for specifically jurisdictional concerns, e.g. Directives, terminologies, formats, etc., an example is specified in the associated Technical Specification[3]. In particular, representation by various coding schemes, additional structures and terminologies are not part of this document. Terminology and its binding are addressed in Reference [3]. The Identification of Medicinal Products standards (abbreviated to IDMP) are the recommended target for the Medication Summary related to this document but, prior to IDMP’s full implementation in practice, this IPS standard cannot insist in its use at this point in time and recognizes that interim schemes might be necessary until IDMP becomes established as a norm.

PDF Catalog

PDF Pages PDF Title
2 undefined
4 European foreword
Endorsement notice
10 Foreword
11 Introduction
13 1 Scope
2 Normative references
3 Terms and definitions
14 3.1 Healthcare
3.2 Healthcare actor
15 3.3 Healthcare matter
3.4 Healthcare activity
3.5 Healthcare planning
16 3.6 Time
3.7 Responsibility
3.8 Information Management
3.8.1 Concepts
17 3.8.2 Models
18 3.8.3 Data
19 3.8.4 Process
20 4 Abbreviations
5 Conformance
5.1 Introduction
22 5.2 IPS Conformance Detail
25 6 Descriptors for the IPS Data Set
26 6.1 Patterns within the IPS Data Set
6.1.1 General
6.1.2 Label Concept
6.1.3 List
27 6.1.4 Reference
6.1.5 Person Name
6.1.6 Coded Element
28 6.1.7 Date Time
6.1.8 Identifier
6.1.9 Address
6.1.10 Telecom
29 6.1.11 Organization Name
6.1.12 Text
6.1.13 Any
6.1.14 Range
6.1.15 Quantity
30 6.1.16 Period
6.1.17 General Time Specification
6.1.18 String
6.1.19 Ratio
31 6.2 Model Extensibility
7 Definition of the IPS Document (IPS)
7.1 Overview Description: THE IPS DOCUMENT (Table 4)
32 7.2 Detailed Description: THE IPS DOCUMENT
35 8 Definition for IPS Attribute Collection: PATIENT ATTRIBUTES
8.1 Overview Description: PATIENT ATTRIBUTES (Table 5)
8.2 Detailed Description: PATIENT ATTRIBUTES
37 9 Definition for IPS Attribute Collection: HEALTHCARE PROVIDER
9.1 Overview Description for HEALTHCARE PROVIDER (Table 6)
9.2 Detailed Description for HEALTHCARE PROVIDER
10 Definition for IPS Attribute Collection: PATIENT’S ADDRESS BOOK
10.1 Overview Description for PATIENT’S ADDRESS BOOK (Table 7)
38 10.2 Detailed Description for PATIENT’S ADDRESS BOOK
39 11 Definition for IPS Section: ADVANCE DIRECTIVES
11.1 Overview Description for ADVANCE DIRECTIVES (Table 8)
40 11.2 Detailed Description for ADVANCE DIRECTIVES
42 12 Definition for IPS Section: ALLERGIES and INTOLERANCES
12.1 Overview Description for ALLERGIES and INTOLERANCES (Table 9)
12.2 Detailed Description for ALLERGIES and INTOLERANCES
46 13 Definition for IPS Section: FUNCTIONAL STATUS
13.1 Overview Description for FUNCTIONAL STATUS (Table 10)
13.2 Detailed Description for FUNCTIONAL STATUS
48 14 Definition for IPS Section: HISTORY OF PAST PROBLEMS
14.1 Overview Description for HISTORY OF PAST PROBLEMS (Table 11)
14.2 Detailed Description for HISTORY OF PAST PROBLEMS
50 15 Definition for IPS Section: HISTORY OF PREGNANCY
15.1 Overview Description for HISTORY OF PREGNANCY (Table 12)
15.2 Detailed Description for HISTORY OF PREGNANCY
53 16 Definition for IPS Section: HISTORY OF PROCEDURES
16.1 Overview Description for HISTORY OF PROCEDURES (Table 13)
16.2 Detailed Description for HISTORY OF PROCEDURES
55 17 Definition for IPS Section: IMMUNIZATIONS
17.1 Overview Description for IMMUNIZATIONS (Table 14)
17.2 Detailed Description for IMMUNIZATIONS
57 18 Definition for IPS Section: MEDICAL DEVICES
18.1 Overview Description for MEDICAL DEVICES (Table 15)
18.2 Detailed Description for MEDICAL DEVICES
58 19 Definition for IPS Section: MEDICATION SUMMARY
19.1 Overview Description for MEDICATION SUMMARY (Tables 16 and 17)
19.2 The IPS Medication Summary and IDMP
59 19.3 Detailed Description for MEDICATION SUMMARY
62 20 Definition for IPS Section: PLAN OF CARE
20.1 Overview Description for PLAN OF CARE (Table 18)
20.2 Detailed Description for PLAN OF CARE
64 21 Definition for IPS Section: PROBLEMS
21.1 Overview Description for PROBLEMS (Table 19)
21.2 Detailed Description for PROBLEMS
66 22 Definition for IPS Section: RESULTS
22.1 Overview Description for RESULTS (Table 20)
22.2 Detailed Description for RESULTS
68 23 Definition for IPS Section: SOCIAL HISTORY
23.1 Overview Description for SOCIAL HISTORY (Table 21)
23.2 Detailed Description for SOCIAL HISTORY
70 24 Definition for IPS Section: VITAL SIGNS
24.1 Overview Description for VITAL SIGNS (Table 22)
24.2 Detailed Description for VITAL SIGNS
72 25 Definition for IPS Attribute Collection: Cross Border
25.1 Overview Description for CROSS BORDER (Table 23)
25.2 Detailed Description for CROSS BORDER
73 26 Definition for IPS Attribute Collection: Provenance Metadata
26.1 Overview Description for PROVENANCE (Table 24)
26.2 Detailed Description for PROVENANCE
75 Annex A (informative) The first IPS Scenario focussed on ‘unscheduled, cross-border care’
82 Annex B (informative) Explicit Trace between eHN Guideline Version 2
86 Annex C (informative) The eHN Guideline, the JIC PS Standards Set, and IPS
87 Bibliography

Related products

BS EN ISO 27269:2022
$215.11